Delivery Order SPE2DB24D2205-SPE2DB25FEEGF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,212.80 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, competitively awarded contract was issued on September 12, 2025, with an ultimate completion date of October 3, 2025. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $41,284.40 for Varivax vaccine with diluents on April 28, 2025, with an ultimate completion date of May 19, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. This award is issued...
- The Defense Logistics Agency awarded a $3,158.88 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of October 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Defense Health Agency and military...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $124.3K by the Defense Logistics Agency on September 3, 2025, with completion targeted for September 24, 2025. The contract calls for the supply of Varivax vaccine with diluents under a firm fixed-price arrangement. This is a non-set-aside award, indicating the contract was competitively awarded. The delivery order is a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $4,211.84 by the Defense Logistics Agency for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is competitively awarded with no set-aside designation. The contract represents a child award under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $157,944 for Varivax vaccine with diluents on June 18, 2025, with an ultimate completion date of July 11, 2025. This firm fixed price contract, which is not set-aside, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $22,761.00 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents one of multiple pharmaceutical procurement...
- The Defense Logistics Agency awarded a $3,096.33 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,085.12 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Varivax vaccine with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of May 12, 2025, and utilizes no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This competitive award, issued on August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEGFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $51,605.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of July 22, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement supporting military healthcare systems globally. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to fulfill diverse medical procurement requirements ranging from small transactions to substantial orders exceeding $45,000. The DLA's broader pharmaceutical procurement strategy includes plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning vendors such as AmerisourceBergen to continue supporting critical military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $51.6k | 6/30/25 |